NEW YORK (GenomeWeb) – KeyGene announced today that it has signed new collaboration agreements with Phenome Networks and the University of Minnesota, and that it has extended its existing partnership with Genalice.

KeyGene and the University of Minnesota said that they have entered a strategic licensing agreement which allows UMN to offer KeyGene’s Sequence-Based Genotyping, and associated genomics services to the academic community and to industry.

KeyGene's SBG technology allows for genome-wide SNP discovery and genotyping for improvement of crops in a single experiment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.